ONCOassist Deployed in The Clatterbridge Cancer Centre as Enterprise System

Portable Medical Technology LtdPortable Medical Technology and The Clatterbridge Cancer Centre NHS Foundation Trust have announced an enterprise agreement which will see ONCOassist, Portable Medical Technology's revolutionary CE approved software system being deployed as the main oncology decision support system used within Clatterbridge.

ONCOassist was launched in January of last year following extensive development involving oncologists, system developers and compliance personnel in Europe and the United States. Since launch ONCOassist has garnered growing acceptance amongst oncology professionals throughout the UK and Ireland. In August of this year, the platform was offered as an enterprise system. This enables individual trusts and institutions to integrate their guidelines and protocols and make them available throughout the trust in an easy to access and intuitive format across multiple mobile operating systems including iOS, Android and Windows.

The Clatterbridge Cancer Centre, based in Wirral, Merseyside, have been working closely with the ONCOassist team over the past twelve months and an enterprise agreement was the logical next step. "After many discussions with Clatterbridge we realised that, as access to the most up to date version of their protocol library was so important, developing a guidelines and protocols engine that allows for the easy integration and updating of trust specific content that can interact with the many CE approved tools already present on the platform would be of huge benefit," said Eoin O’Carroll of ONCOassist.

Thomas Poulter, Head of IM&T at The Clatterbridge Cancer Centre, said: "Having ONCOassist available in clinics and on the wards will save our clinicians time. The oncology nurses and clinicians will have access to all of the key oncology decision support information and tools they need. For example, our nurses often need to reference protocols or treatment algorithms when delivering chemotherapy treatment. ONCOassist makes it easy to do this."

Jo Upton, Skin Cancer Advanced Nurse Practitioner at The Clatterbridge Cancer Centre, said: "A cancer nurse's role is continually evolving to meet the needs of our patients. Important decisions relating to the management of treatment side-effects and the patient experience of their treatment are fast becoming central to the cancer nurse's role, especially in the outpatient setting. It is essential that vital information to aid decision-making in practice is quick and easy to access. I have found that the ONCOassist app provides easy access to formulas and decision-support information in my day-to-day job."

Kevin Bambury of ONCOassist said: "We are delighted to have The Clatterbridge Cancer Centre as the first NHS trust using our enterprise system. We look forward to working with them over the coming years as we continue to add features and functionality to the system."

About Portable Medical Technology
Portable Medical Technology Ltd develops quality, accredited and trusted apps for medical specialists to reduce medical errors, improve efficiencies and progress patient communication. We combine the essential tools specialists need into a single, easy-to-use smartphone and table application that are FDA and CE approved and provide the latest updated tools to support critical medical decision-making.

Most Popular Now

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Digital ECGs at Barts Health: A High-Imp…

Opinion Article by Dr Krishnaraj Sinhji Rathod, consultant in interventional cardiology, Barts Health NHS Trust. Picture the moment. A patient in an ambulance, enroute to hospital with new chest pain. Paramedics...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

Study Sheds Light on Hurdles Faced in Tr…

Implementing artificial intelligence (AI) into NHS hospitals is far harder than initially anticipated, with complications around governance, contracts, data collection, harmonisation with old IT systems, finding the right AI tools...

Using Deep Learning for Precision Cancer…

Altuna Akalin and his team at the Max Delbrück Center have developed a new tool to more precisely guide cancer treatment. Described in a paper published in Nature Communications, the...

New AI Approach Paves Way for Smarter T-…

Researchers have harnessed the power of artificial intelligence (AI) to tackle one of the most complex challenges in immunology: predicting how T cells recognize and respond to specific peptide antigens...

Study Used AI Models to Improve Predicti…

Chronic kidney disease (CKD) is a complex condition marked by a gradual decline in kidney function, which can ultimately progress to end-stage renal disease (ESRD). Globally, the prevalence of the...

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...